Skip to main content

Risk Factors Associated with Development of Acute and Sub-Acute Post-Cesarean Pain: A Prospective Cohort Study.

Publication ,  Journal Article
Chan, JJI; Tan, CW; Yeam, CT; Sultana, R; Sia, ATH; Habib, AS; Sng, BL
Published in: J Pain Res
2020

BACKGROUND: Although cesarean delivery is one of the most commonly performed surgical procedures, robust data regarding post-cesarean pain is still lacking. Recent studies showed an association between pain upon local anesthetic (LA) injection for spinal anesthesia, or the use of a "three simple questions", and acute post-cesarean pain. Nevertheless, these assessments have yet to be validated further, despite their relative ease of use. We aimed to assess the association between pain score upon LA injection with acute post-cesarean pain after 24 hours at rest (primary outcome) and sub-acute post-cesarean pain lasting for 4 weeks or more (secondary outcome). METHODS: Women undergoing cesarean delivery under spinal anesthesia were given pre-operative questionnaires on pain and psychological vulnerability. We also assessed the pain score upon LA injection and mechanical temporal summation. Univariate and multivariable logistic regressions were performed. RESULTS: The incidence of moderate-to-severe acute post-cesarean pain at 24 hours was 21.0% (95% CI=16.6-27.6%) (48 of 217 patients). Pain score upon LA injection was not significantly associated with acute post-cesarean pain after 24 hours at rest (unadjusted OR=1.10, 95% CI=0.95-1.27, P=0.21). However, pain score upon LA injection was significantly associated with sub-acute post-cesarean pain (adjusted OR=1.29, 95% CI=1.07-1.55, P=0.0089) with significant covariate of increased pre-operative central sensitization inventory (CSI) scores (adjusted OR=1.05, 95% CI=1.01-1.09, P=0.0111; area under the curve (AUC)=0.691). CONCLUSION: There was no association between increased pain score upon LA injection and acute post-cesarean pain, but it was associated with sub-acute post-cesarean pain. Further work is needed to define pain score upon LA injection as a convenient pragmatic measure of risk stratifying patients predisposed to sub-acute post-cesarean pain.

Duke Scholars

Published In

J Pain Res

DOI

ISSN

1178-7090

Publication Date

2020

Volume

13

Start / End Page

2317 / 2328

Location

New Zealand

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chan, J. J. I., Tan, C. W., Yeam, C. T., Sultana, R., Sia, A. T. H., Habib, A. S., & Sng, B. L. (2020). Risk Factors Associated with Development of Acute and Sub-Acute Post-Cesarean Pain: A Prospective Cohort Study. J Pain Res, 13, 2317–2328. https://doi.org/10.2147/JPR.S257442
Chan, Jason Ju In, Chin Wen Tan, Cheng Teng Yeam, Rehena Sultana, Alex Tiong Heng Sia, Ashraf Samir Habib, and Ban Leong Sng. “Risk Factors Associated with Development of Acute and Sub-Acute Post-Cesarean Pain: A Prospective Cohort Study.J Pain Res 13 (2020): 2317–28. https://doi.org/10.2147/JPR.S257442.
Chan JJI, Tan CW, Yeam CT, Sultana R, Sia ATH, Habib AS, et al. Risk Factors Associated with Development of Acute and Sub-Acute Post-Cesarean Pain: A Prospective Cohort Study. J Pain Res. 2020;13:2317–28.
Chan, Jason Ju In, et al. “Risk Factors Associated with Development of Acute and Sub-Acute Post-Cesarean Pain: A Prospective Cohort Study.J Pain Res, vol. 13, 2020, pp. 2317–28. Pubmed, doi:10.2147/JPR.S257442.
Chan JJI, Tan CW, Yeam CT, Sultana R, Sia ATH, Habib AS, Sng BL. Risk Factors Associated with Development of Acute and Sub-Acute Post-Cesarean Pain: A Prospective Cohort Study. J Pain Res. 2020;13:2317–2328.

Published In

J Pain Res

DOI

ISSN

1178-7090

Publication Date

2020

Volume

13

Start / End Page

2317 / 2328

Location

New Zealand

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1103 Clinical Sciences